Commercial Space Stations Open for Bookings as ISS Retirement Looms

Three private companies began selling reservations for stays on commercial space stations this month, marking the transition of low-Earth orbit from a government monopoly to a private market. The offerings range from $5 million for a three-day research mission to $55 million for a two-week orbital stay, and they arrive as NASA accelerates plans to decommission the International Space Station by 2030.

Axiom Space, the most advanced of the three, has already launched four crewed missions to the ISS using SpaceX Crew Dragon capsules and is now constructing its own station modules. The first Axiom module is scheduled to launch and attach to the ISS in late 2027, with the station becoming fully independent by 2031. Axiom is selling research time, sovereign astronaut missions for nations without space programs, and manufacturing facilities for companies interested in producing materials in microgravity.

"The ISS was a laboratory. Our station is a platform," said Michael Suffredini, Axiom's CEO and former ISS program manager. "We are building infrastructure that allows any organization — a university, a pharmaceutical company, a foreign government — to operate in space without needing to build their own space program."

Orbital Reef, a joint venture between Jeff Bezos's Blue Origin and Sierra Space, began accepting deposits for research and manufacturing space aboard its planned station. The design features inflatable habitat modules that offer significantly more interior volume per launch than rigid designs. Orbital Reef is targeting initial operations by 2028 and has signed letters of intent from 14 universities and 6 pharmaceutical companies.

Starlab, a partnership between Lockheed Martin and Nanoracks, is targeting a 2029 launch with a different business model. Rather than selling individual stays, Starlab offers "orbital real estate" — dedicated modules that clients can outfit for their own purposes. The Luxembourg government has reserved a module for materials science research, and an agricultural biotechnology firm has leased space for crop optimization experiments.

The market drivers extend beyond research. Pharmaceutical companies are interested in microgravity protein crystallization, which can produce drug formulations impossible to manufacture on Earth. A cancer drug crystallized aboard the ISS showed 40% improved bioavailability in preclinical trials, and companies are eager to move from experimental to production-scale manufacturing. Semiconductor manufacturers are exploring whether the absence of convection in microgravity allows for more uniform crystal growth, potentially producing chips with fewer defects.

NASA's Commercial Low Earth Orbit Development program, which has invested $500 million in the private station initiatives, views the transition as essential. Maintaining the ISS costs $3 billion to $4 billion annually, and the agency wants to redirect those funds toward deep space exploration, including the Artemis lunar program and eventual Mars missions.

"The goal is to be one of many customers in low-Earth orbit, rather than the sole operator," said Phil McAlister, director of NASA's commercial space division. "We want to create a market where private companies compete to provide services, and NASA buys what it needs. That model has worked brilliantly for cargo and crew transportation. We believe it will work for destinations as well."

Skeptics question whether the market is large enough to support three competing stations. The total addressable market for commercial space station services is estimated at $6 billion to $12 billion annually by 2035 — enough for one or two profitable operators, but potentially not three. A shakeout seems likely.

Safety and regulatory frameworks also remain unsettled. The FAA's commercial spaceflight regulations were written for launch and reentry, not for continuous orbital habitation. Questions about liability, insurance, and emergency response protocols for private stations are unresolved. An incident aboard a commercial station — a fire, a decompression, a medical emergency — would test legal frameworks that have never been exercised.

For now, the demand signal is strong enough to justify the investment. Axiom's mission manifest is booked through 2028, and all three companies report growing pipelines of prospective clients. The era of private space stations is arriving, and with it, a new chapter in humanity's relationship with orbit.